The role of mathematical modelling in guiding the science and economics of malaria elimination

International Health

Volumn 2, Issue 4, 2010, Pages 239-246

  Maude, Richard J ^a,b,c   Lubell, Yoel ^a,b   Socheat, Duong ^d   Yeung, Shunmay ^e   Saralamba, Sompob ^a   Pongtavornpinyo, Wirichada ^a   Cooper, Ben S ^a,b   Dondorp, Arjen M ^a,b   White, Nicholas J ^a,b   White, Lisa J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d National Malaria Center   (Cambodia)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Control; Economic; Malaria; Mathematical modelling; Model; Policy

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; CHLOROQUINE; LARVICIDAL AGENT;

COST BENEFIT ANALYSIS; DISEASE SURVEILLANCE; ECONOMIC EVALUATION; EPIDEMIOLOGICAL DATA; FUNDING; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; MALARIA; MALARIA CONTROL; MATHEMATICAL MODEL; PRIORITY JOURNAL; REVIEW; STATISTICAL MODEL; SUPERINFECTION;

EID: 78649631980     PISSN: 18763413     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inhe.2010.09.005     Document Type: Review

References (41)

1. Mendis K., Rietveld A., Warsame M., Bosman A., Greenwood B., Wernsdorfer W.H. From malaria control to eradication: the WHO perspective. Trop Med Int Health 2009, 14:802-809.
2. McKenzie F.E. The role of mathematical modelling in evidence-based malaria control. Am J Trop Med Hyg 2004, 71:94-96.
3. Maude R.J., Pontavornpinyo W., Saralamba S., Aguas R., Yeung S., Dondorp A.M., et al. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J 2009, 8:31.
4. White L.J., Maude R.J., Pongtavornpinyo W., Saralamba S., Aguas R., Van Effelterre T., et al. The role of simple mathematical models in malaria elimination strategy design. Malar J 2009, 8:212.
5. Morel C.M., Lauer J.A., Evans D.B. Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ 2005, 331:1299. Erratum in: BMJ 2006;332:151; BMJ 2006;333:86.
6. MalERA. MalERA Consultative Meeting Report. Modeling, February 23-24, 2009, Washington D.C., USA. Malaria Eradication Research Agenda. [accessed 7 March 2010]. http://malera.tropika.net/consultative-groups/modeling/public-documents/MalERA-Modeling%20meeting%20executive%20summary-Washington%20February%2023-24.pdf/at_download/file.
7. Song J., Socheat D., Tan B., Dara P., Deng C., Sokunthea S., et al. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J 2010, 9:57.
8. McKenzie F.E. Why model malaria?. Parasitol Today 2000, 16:511-516.
9. Molineaux L. The pros and cons of modelling malaria transmission. Trans R Soc Trop Med Hyg 1985, 79:743-747.
10. Harrison G. Mosquitoes, malaria and man 1978, Clark, Irwin and Co, New York, NY.
11. MacDonald G. The epidemiology and control of malaria 1957, Oxford University Press, London, UK.
12. Nájera J.A. A critical review of the field application of a mathematical model of malaria eradication. Bull World Health Organ 1974, 50:449-457.
13. Koella J.C. On the use of mathematical models of malaria transmission. Acta Trop 1991, 49:1-25.
14. Molineaux L, Grammacia G. The Garki Project. Geneva: World Health Organization; 1980, pp. 261-88.
15. Smith D.L., Hay S.I. Endemicity response timelines for Plasmodium falciparum elimination. Malar J 2009, 8:87.
16. Edmunds W.J., Medley G.F., Nokes D.J. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med 1999, 18:3263-3282.
17. Vynnycky E., Pitman R., Siddiqui R., Gay N., Edmunds W.J. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine 2008, 26:5321-5330.
18. Sadique M.Z., Adams E.J., Edmunds W.J. Estimating the costs of school closure for mitigating an influenza pandemic. BMC Public Health 2008, 8:135.
19. Aguas R., White L.J., Snow R.W., Gomes M.G.M. Prospects for malaria eradication in sub-Saharan Africa. PLoS One 2008, 3:e1767.
20. Smith T., Maire N., Dietz K., Killeen G.F., Vounatsou P., Molineaux L., et al. Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am J Trop Med Hyg 2006, 75(2 Suppl):11-18.
21. Maude R.J., Pontavornpinyo W., Saralamba S., Dondorp A.M., Day N.P., White N.J., et al. The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?). Trans R Soc Trop Med Hyg 2009, 103:643-644.
22. Aguas R., Lourenço J.M., Gomes M.G., White L.J. The impact of IPTi and IPTc interventions on malaria clinical burden-in silico perspectives. PLoS One 2009, 4:e6627.
23. Okell L.C., Drakeley C.J., Bousema T., Whitty C.J., Ghani A.C. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 2008, 5:e226.
24. Yeung S., Pongtavornpinyo W., Hastings I.M., Mills A.J., White N.J. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg 2004, 71:179-186.
25. Penny M.A., Maire N., Studer A., Schapira A., Smith T.A. What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines. PLoS One 2008, 3:e3193.
26. Killeen G.F., McKenzie F.E., Foy B.D., Schieffelin C., Billingsley P.F., Beier J.C. The potential impact of integrated malaria transmission control on entomologic inoculation rate in highly endemic areas. Am J Trop Med Hyg 2000, 62:545-551.
27. McKenzie F.E., Baird J.K., Beier J.C., Lal A.A., Bossert W.H. A biologic basis for integrated malaria control. Am J Trop Med Hyg 2002, 67:571-577.
28. Carter R., Mendis K.N., Roberts D. Spatial targeting of interventions against malaria. Bull World Health Organ 2000, 78:1401-1411.
29. Carter R. Spatial simulation of malaria transmission and its control by malaria transmission blocking vaccination. Int J Parasitol 2002, 32:1617-1624.
30. Division of Malaria Control, Ministry of Public Health and Sanitation. Kenya Malaria Monitoring and Evaluation Plan 2009-2017. Nairobi, Kenya: Division of Malaria Control, Ministry of Public Health and Sanitation; 2009. [accessed 1 January 2010]. http://www.nmcp.or.ke/documents/Malaria%20Monitoring%20and%20Evaluation%20Plan%20Kenya%202009-2017.pdf.
31. Mills A., Lubell Y., Hanson K. Malaria eradication: the economic, financial and institutional challenge. Malar J 2008, 7(Suppl 1):S11.
32. Sachs J., Malaney P. The economic and social burden of malaria. Nature 2002, 415:680-685.
33. Roll Back Malaria. The Global Malaria Action Plan. Geneva: Roll Back Malaria Partnership; 2008. [accessed 11 March 2010]. http://www.rollbackmalaria.org/gmap/gmap.pdf.
34. Cibulskis R.E., Bell D., Christophel E.M., Hii J., Delacollette C., Bakyaita N., et al. Estimating trends in the burden of malaria at country level. Am J Trop Med Hyg 2007, 77:133-137.
35. Cohn E. Assessing the costs and benefits of anti-malaria programs: the Indian experience. Am J Public Health 1973, 63:1086-1096.
36. Weinstein M.C. Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics 2006, 24:1043-1053.
37. Resch S.C., Salomon J.A., Murray M., Weinstein M.C. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med 2006, 3:e241.
38. Currie C.S., Floyd K., Williams B.G., Dye C. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. BMC Public Health 2005, 5:130.
39. Baguelin M., Hoek A.J., Jit M., Flasche S., White P.J., Edmunds W.J. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine 2010, 28:2370-2384.
40. Jit M., Choi Y.H., Edmunds W.J. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008, 337:a769.
41. Hay S.I., Snow R.W. The Malaria Atlas Project: developing global maps of malaria risk. PLoS Med 2006, 3:e473.